&
Chronic hepatitis D is frequently the most aggressive form of viral hepatitis. In approximately 15% of patients, rapid progression to cirrhosis is seen. As yet, there is no established effective treatment for hepatitis D, although interferon-α-2a may be a promising candidate. Recent data on the use of interferon and other agents in the management of hepatitis D, along with new studies on the diagnosis and pathogenesis of the condition, were presented at the 5th International Symposium on Hepatitis Delta Virus and Liver Disease [ Gold Coast, Australia; August 1995 ].
Rights and permissions
About this article
Cite this article
Higgins, G. Assessing the value of interferons in hepatitis D. Inpharma Wkly. 1004, 13–14 (1995). https://doi.org/10.2165/00128413-199510040-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199510040-00027